Liver fibrosis for the dermatologist: a review.

Bibliographic Details
Title: Liver fibrosis for the dermatologist: a review.
Authors: Raahimi, Mina M, Livesey, Amy, Hamilton, Jessica, Shipman, Alexa R, Aspinall, Richard J
Source: Clinical & Experimental Dermatology; Apr2023, Vol. 48 Issue 4, p303-309, 7p, 3 Diagrams, 3 Charts
Subject Terms: HEPATIC fibrosis, FATTY liver, NON-alcoholic fatty liver disease, DERMATOLOGISTS
Abstract: Methotrexate-induced liver fibrosis is not a well-defined pathology, and many of the reported cases can instead be classified as nonalcoholic fatty liver disease by current diagnostic criteria, which is particularly common in the psoriasis cohort. Liver fibrosis usually takes many years to progress; therefore, screening for liver fibrosis should be done no more regularly than annually at the very most in dermatology practice. An algorithm is presented about how to investigate abnormal liver blood tests and screening tools for liver fibrosis are compared. [ABSTRACT FROM AUTHOR]
Copyright of Clinical & Experimental Dermatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:03076938
DOI:10.1093/ced/llac083
Published in:Clinical & Experimental Dermatology
Language:English